|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to the designation of centers of excellence for the early |
|
diagnosis and treatment of placental disorders. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Chapter 32, Health and Safety Code, is amended by |
|
adding Subchapter E to read as follows: |
|
SUBCHAPTER E. CENTERS OF EXCELLENCE FOR EARLY DIAGNOSIS AND |
|
TREATMENT OF PLACENTAL DISORDERS |
|
Sec. 32.101. DEFINITION. In this subchapter, "placental |
|
disorder" includes placenta accreta, placenta increta, and |
|
placenta percreta. |
|
Sec. 32.102. DESIGNATION OF CENTERS OF EXCELLENCE. (a) The |
|
department, in consultation with the maternal mortality and |
|
morbidity task force established under Chapter 34, shall designate |
|
as centers of excellence for the early diagnosis and treatment of |
|
placental disorders one or more health care entities or programs in |
|
this state, including institutions of higher education or programs |
|
of those institutions. |
|
(b) The executive commissioner, in consultation with the |
|
department and the maternal mortality and morbidity task force, |
|
shall adopt rules necessary for a health care entity or program in |
|
this state to be designated as a center of excellence for early |
|
diagnosis and treatment of placental disorders. |
|
Sec. 32.103. SUBCOMMITTEE. (a) The department, in |
|
consultation with the maternal mortality and morbidity task force, |
|
shall appoint a subcommittee of the task force to advise the |
|
executive commissioner on the adoption of rules under Section |
|
32.102. As part of the subcommittee's duties under this |
|
subsection, the subcommittee specifically shall advise the |
|
executive commissioner on the criteria necessary for a health care |
|
entity or program in this state to receive a designation under this |
|
subchapter. |
|
(b) The subcommittee must consist of individuals with |
|
expertise in the early diagnosis and treatment of placental |
|
disorders. A majority of the members of the subcommittee must |
|
practice in those areas in a health profession in this state. The |
|
subcommittee may include national and international experts. |
|
Sec. 32.104. PRIORITY CONSIDERATIONS FOR CENTER |
|
DESIGNATIONS. The rules adopted under Section 32.102 must |
|
prioritize awarding a designation under this subchapter to a health |
|
care entity or program that: |
|
(1) offers early diagnosis and treatment services for |
|
placental disorders through a multi-specialty clinical program |
|
that is affiliated and collaborates extensively with a medical |
|
school in this state and an associated hospital that provides |
|
advanced maternal and neonatal care in accordance with the |
|
hospital's level of care designation received under Section |
|
241.182; |
|
(2) demonstrates a significant commitment to research |
|
in and advancing the field of placental disorder care; |
|
(3) offers advanced training programs in the early |
|
diagnosis and treatment of placental disorders; and |
|
(4) integrates an advanced placental disorder care |
|
program with a program that provides appropriate long-term |
|
monitoring and follow-up care for patients. |
|
Sec. 32.105. REQUIREMENTS FOR DESIGNATION. The rules |
|
adopted under Section 32.102 must ensure that a health care entity |
|
or program in this state that receives a center of excellence |
|
designation under this subchapter: |
|
(1) provides or is affiliated with a hospital that |
|
provides advanced maternal and neonatal care in accordance with the |
|
hospital's level of care designation received under Section |
|
241.182; |
|
(2) implements and maintains a multidisciplinary |
|
health care team, including maternal fetal medicine specialists, |
|
pediatric and surgical specialists, neonatologists, nurses with |
|
specialized maternal and neonatal training, and other ancillary and |
|
support staff as appropriate to provide care related to placental |
|
disorders; |
|
(3) establishes minimum criteria for medical staff, |
|
nursing staff, and ancillary and support staff; |
|
(4) measures short-term and long-term patient |
|
diagnostic and therapeutic outcomes; and |
|
(5) provides to the department annual reports |
|
containing aggregate data on short-term and long-term diagnostic |
|
and therapeutic outcomes as requested or required by the department |
|
and makes those reports available to the public on the entity's or |
|
program's Internet website. |
|
SECTION 2. (a) Not later than December 1, 2019, the |
|
Department of State Health Services, in consultation with the |
|
maternal mortality and morbidity task force established under |
|
Chapter 34, Health and Safety Code, shall appoint members to the |
|
subcommittee as required by Section 32.103, Health and Safety Code, |
|
as added by this Act. |
|
(b) Not later than December 1, 2020, the executive |
|
commissioner of the Health and Human Services Commission shall |
|
adopt rules as required by Section 32.102, Health and Safety Code, |
|
as added by this Act. |
|
(c) Not later than September 1, 2021, the Department of |
|
State Health Services shall begin awarding designations of centers |
|
of excellence as required by Subchapter E, Chapter 32, Health and |
|
Safety Code, as added by this Act. |
|
SECTION 3. This Act takes effect September 1, 2019. |